1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with Colorectal Cancer in 1 studies
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol: a sphingolipid analog; inhibits the enzyme activity in infected erythrocytes
N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide : A fatty amide resulting from the formal condensation of palmitic acid with the primary amino group of 2-amino-3-(morpholin-4-yl)-1-phenylpropan-1-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Irinotecan is a first-line chemotherapeutic agent for patients with metastatic colorectal cancer (CRC)." | 3.72 | Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy. ( Bilchik, AJ; Cabot, MC; Litvak, DA, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Litvak, DA | 1 |
| Bilchik, AJ | 1 |
| Cabot, MC | 1 |
1 other study available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and Colorectal Cancer
| Article | Year |
|---|---|
Modulators of ceramide metabolism sensitize colorectal cancer cells to chemotherapy: a novel treatment strategy.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Survival; Ceramides; Colorectal Neo | 2003 |